Ezetimibe/Simvastatin Combo Lowers LDL in Type 2 Diabetes
FRIDAY, Sept. 3 (HealthDay News) -- For patients with type 2 diabetes who are not meeting recommended low-density lipoprotein (LDL) cholesterol goals, adding ezetimibe to simvastatin treatment significantly increases the likelihood of reaching an LDL cholesterol level below 70 mg/dL, according to a study published in the September issue of Diabetes Care.